https://www.marketscreener.com/quote/stock/HUTCHMED-CHINA-LIMITED-26786463/news/HUTCHMED-Highlights-Presentation-of-Phase-III-Data-on-Fruquintinib-in-Second-Line-Gastric-Cancer-at-45897439/?utm_source=telegram&utm_medium=social&utm_campaign=share